Navigation Links
SciClone To Present At BIO CEO & Investor Conference On February 9, 2016
Date:1/27/2016

FOSTER CITY, Calif., Jan. 27, 2016 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that Friedhelm Blobel, Ph.D., Chief Executive Officer, will present a corporate overview and business update at the 18th Annual BIO CEO & Investor Conference at 8:30 am ET on Tuesday, February 9, 2016, at the Waldorf Astoria Hotel in New York City.

 

To access the live audio webcast of these presentations, please log on through a link located in the Investor Relations section of SciClone's website at www.sciclone.com, under the Calendar of Events tab. A replay of the webcast will be available one hour after the conclusion of the live events.

About SciClone

SciClone Pharmaceuticals is a revenue-generating, specialty pharmaceutical company with a substantial commercial business in China and a product portfolio spanning major therapeutic markets including oncology, infectious diseases and cardiovascular disorders. SciClone's proprietary lead product, ZADAXIN® (thymalfasin), is approved in over 30 countries and may be used for the treatment of hepatitis B (HBV), hepatitis C (HCV), and certain cancers, and as a vaccine adjuvant, according to the local regulatory approvals. The Company has successfully in-licensed and commercialized products with the potential to become future market leaders and to drive the Company's long-term growth, including DC Bead®, a novel treatment for liver cancer. Through its promotion business with pharmaceutical partners, SciClone also markets multiple branded products in China which are therapeutically differentiated. SciClone is a publicly-held corporation based in Foster City, California, and trades on the NASDAQ Global Select Market under the symbol SCLN. For additional information, please visit www.sciclone.com.

Forward-Looking Statements

This press release contains forward-looking statements regarding expected financial results and expectations. Readers are urged to consider statements that include the words "may," "will," "would," "could," "should," "might," "believes," "estimates," "projects," "potential," "expects," "plans," "anticipates," "intends," "continues," "forecast," "designed," "goal," "unaudited," "approximately" or the negative of those words or other comparable words to be uncertain and forward-looking. These statements are subject to risks and uncertainties that are difficult to predict and actual outcomes may differ materially.  Please also refer to other risks and uncertainties described in SciClone's filings with the SEC. All forward-looking statements are based on information currently available to SciClone and SciClone assumes no obligation to update any such forward-looking statements.

SciClone, SciClone Pharmaceuticals, the SciClone Pharmaceuticals design, the SciClone logo and ZADAXIN are registered trademarks of SciClone Pharmaceuticals, Inc. in the United States and numerous other countries.

Corporate Contacts Wilson W. CheungJane GreenChief Financial OfficerInvestors/Media650.358.3434650.358.1447wcheung@sciclone.comjgreen@sciclone.com

Logo - http://photos.prnewswire.com/prnh/20150722/240358LOGO


'/>"/>
SOURCE SciClone Pharmaceuticals, Inc.
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. SciClone Announces Preliminary 2015 Revenue
2. SciClone Reports Third Quarter 2015 Financial Results
3. SciClone To Present At Boston Biotech NY/NJ CEO Conference On November 12th
4. SciClone Pharmaceuticals To Report Financial Results For The Third Quarter 2015 On November 9th
5. SciClone To Present At 2015 Aegis Capital Growth Conference On October 9th
6. SciClone To Present At Two Investor Conferences On September 10, 2015
7. Xcovery to Present at 25th Annual Florida Venture Capital Conference
8. Ampios OptimEyes Study Results to be presented at The Association for Research in Vision and Ophthalmology (ARVO)
9. RXi Pharmaceuticals to Present at the 18th Annual BIO CEO & Investor Conference
10. NW Bio Presenting At Phacilitate Immunotherapy World Forum
11. AcelRx Pharmaceuticals Announces Presentation of Phase 3 Sufentanil Sublingual 30 mcg Tablet (ARX-04) Data at the European Congress of Ambulatory Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2020)... (PRWEB) , ... March 30, 2020 , ... ... is launching a new solution, TalkWithYourDoc.com . By leveraging technology developed ... providers of all sizes to continue offering revenue-generating healthcare services while serving patients’ ...
(Date:3/30/2020)... ... March 30, 2020 , ... Representatives with Miami-based Tattoo ... Technician' service. , "We are very excited to offer this service," said Barbara ... the Institute of Tattoo Removal is available to answer any questions or concerns ...
(Date:3/28/2020)... , ... March 28, 2020 , ... TriageLogic, a leader ... to use telehealth system with a virtual call center that hospitals, medical organizations, and ... organizations adapt to the coronavirus pandemic, they are looking for a system that can ...
Breaking Medicine Technology:
(Date:3/22/2020)... ... March 21, 2020 , ... TriageLogic, ... that hospitals, medical organizations, and health centers can use for patient care during ... pandemic, many medical professionals are working around the clock to implement emergency support ...
(Date:3/20/2020)... ... March 20, 2020 , ... My heart goes out ... from COVID-19. Having also lost a loved one recently through similar circumstances - underlying ... few days, I have felt a gamut of negative emotions just like many have: ...
(Date:3/20/2020)... ... March 21, 2020 , ... The Healthcare ... for a day of live discussion and learning online. Experts will provide helpful ... whistleblower laws, the role of boards, fraud, waste and abuse, and privacy and ...
(Date:3/19/2020)... ... March 19, 2020 , ... ... teach Executive Function, shares a free Student Learning Exercise: ExQ® Superpower Hour. ... and teachers are seeking resources to help with the immediate need for activities ...
(Date:3/19/2020)... ... March 19, 2020 , ... “We wanted to solve the challenges of ... Patel, Founder of Radish Health. “A reliable at home testing kit that can be ... they need in the comfort of their own home, while maintaining the health of ...
Breaking Medicine News(10 mins):